Edition:
India

Transgene: Positive Results Of TG1050 Phase 1 Clinical Trial In Chronic Hepatitis B


Monday, 12 Nov 2018 

Nov 12 (Reuters) - TRANSGENE SA ::POSITIVE RESULTS FROM PHASE 1 CLINICAL TRIAL OF TG1050 IN CHRONIC HEPATITIS B.PRIMARY END-POINT REACHED.TG1050 TRIGGERS T CELL-BASED IMMUNE RESPONSES.NEW PRECLINICAL DATA CLEARLY SUPPORT FURTHER INVESTIGATION OF TG1050 IN COMBINATION WITH ANTIVIRALS OR IMMUNOMODULATORS.NEW AND ENCOURAGING PRECLINICAL DATA SHOWING IMPROVED ANTIVIRAL ACTIVITY OF TG1050 WHEN ADMINISTERED IN COMBINATION WITH EITHER ANTIVIRALS OR IMMUNOMODULATORS IN HBV-PERSISTENT MICE.